APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiopulmonary Autotransfusion System

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

Selected research

Industry Research

Cardiopulmonary Autotransfusion System Industry Research Report 2026

1 January 2026122 pages

Choose your research edition.

Industry ResearchCardiopulmonary Autotransfusion System Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiopulmonary Autotransfusion System Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Cardiopulmonary Autotransfusion System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiopulmonary Autotransfusion System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiopulmonary Autotransfusion System Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Read the full market overview

Report Scope

This report quantifies the global Cardiopulmonary Autotransfusion System market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiopulmonary Autotransfusion System Market by Company

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

Cardiopulmonary Autotransfusion System Segment by Type

Unwashed ATS

Washed ATS

Cardiopulmonary Autotransfusion System Segment by Application

Heart Surgery

Great Organ Transplant Surgery

Other Surgery

Cardiopulmonary Autotransfusion System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiopulmonary Autotransfusion System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiopulmonary Autotransfusion System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiopulmonary Autotransfusion System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cardiopulmonary Autotransfusion System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cardiopulmonary Autotransfusion System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiopulmonary Autotransfusion System Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cardiopulmonary Autotransfusion System Sales (Units) of Manufacturers (2021-2026) Table 7. Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cardiopulmonary Autotransfusion System Revenue of Manufacturers (2021-2026) Table 9. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cardiopulmonary Autotransfusion System Average Price (K US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cardiopulmonary Autotransfusion System Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cardiopulmonary Autotransfusion System, Product Type & Application Table 14. Global Cardiopulmonary Autotransfusion System Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cardiopulmonary Autotransfusion System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Haemonetics Company Information Table 19. Haemonetics Business Overview Table 20. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 21. Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio Table 22. Haemonetics Recent Developments Table 23. Medtronic Company Information Table 24. Medtronic Business Overview Table 25. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 26. Medtronic Cardiopulmonary Autotransfusion System Product Portfolio Table 27. Medtronic Recent Developments Table 28. LivaNova Company Information Table 29. LivaNova Business Overview Table 30. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 31. LivaNova Cardiopulmonary Autotransfusion System Product Portfolio Table 32. LivaNova Recent Developments Table 33. Fresenius Kabi Company Information Table 34. Fresenius Kabi Business Overview Table 35. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 36. Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio Table 37. Fresenius Kabi Recent Developments Table 38. Terumo Company Information Table 39. Terumo Business Overview Table 40. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 41. Terumo Cardiopulmonary Autotransfusion System Product Portfolio Table 42. Terumo Recent Developments Table 43. Wandong Health Sources Company Information Table 44. Wandong Health Sources Business Overview Table 45. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 46. Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio Table 47. Wandong Health Sources Recent Developments Table 48. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 49. Global Cardiopulmonary Autotransfusion System Sales by Region (2021-2026) & (Units) Table 50. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2021-2026) Table 51. Global Cardiopulmonary Autotransfusion System Sales by Region (2027-2032) & (Units) Table 52. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2027-2032) Table 53. Global Cardiopulmonary Autotransfusion System Revenue by Region (2021-2026) & (US$ Million) Table 54. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2021-2026) Table 55. Global Cardiopulmonary Autotransfusion System Revenue by Region (2027-2032) & (US$ Million) Table 56. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2027-2032) Table 57. North America Cardiopulmonary Autotransfusion System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. North America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 59. North America Cardiopulmonary Autotransfusion System Sales by Country (2027-2032) & (Units) Table 60. North America Cardiopulmonary Autotransfusion System Revenue by Country (2021-2026) & (US$ Million) Table 61. North America Cardiopulmonary Autotransfusion System Revenue by Country (2027-2032) & (US$ Million) Table 62. Europe Cardiopulmonary Autotransfusion System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Europe Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 64. Europe Cardiopulmonary Autotransfusion System Sales by Country (2027-2032) & (Units) Table 65. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2021-2026) & (US$ Million) Table 66. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2027-2032) & (US$ Million) Table 67. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 69. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Country (2027-2032) & (Units) Table 70. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Country (2021-2026) & (US$ Million) Table 71. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Country (2027-2032) & (US$ Million) Table 72. South America Cardiopulmonary Autotransfusion System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. South America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 74. South America Cardiopulmonary Autotransfusion System Sales by Country (2027-2032) & (Units) Table 75. South America Cardiopulmonary Autotransfusion System Revenue by Country (2021-2026) & (US$ Million) Table 76. South America Cardiopulmonary Autotransfusion System Revenue by Country (2027-2032) & (US$ Million) Table 77. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 79. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2027-2032) & (Units) Table 80. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2021-2026) & (US$ Million) Table 81. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2027-2032) & (US$ Million) Table 82. Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 83. Global Cardiopulmonary Autotransfusion System Sales by Type (2027-2032) & (Units) Table 84. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021-2026) Table 85. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2027-2032) Table 86. Global Cardiopulmonary Autotransfusion System Revenue by Type (2021-2026) & (US$ Million) Table 87. Global Cardiopulmonary Autotransfusion System Revenue by Type (2027-2032) & (US$ Million) Table 88. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021-2026) Table 89. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2027-2032) Table 90. Global Cardiopulmonary Autotransfusion System Price by Type (2021-2026) & (K US$/Unit) Table 91. Global Cardiopulmonary Autotransfusion System Price by Type (2027-2032) & (K US$/Unit) Table 92. Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 93. Global Cardiopulmonary Autotransfusion System Sales by Application (2027-2032) & (Units) Table 94. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021-2026) Table 95. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2027-2032) Table 96. Global Cardiopulmonary Autotransfusion System Revenue by Application (2021-2026) & (US$ Million) Table 97. Global Cardiopulmonary Autotransfusion System Revenue by Application (2027-2032) & (US$ Million) Table 98. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021-2026) Table 99. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2027-2032) Table 100. Global Cardiopulmonary Autotransfusion System Price by Application (2021-2026) & (K US$/Unit) Table 101. Global Cardiopulmonary Autotransfusion System Price by Application (2027-2032) & (K US$/Unit) Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Cardiopulmonary Autotransfusion System Distributors List Table 105. Cardiopulmonary Autotransfusion System Customers List Table 106. Cardiopulmonary Autotransfusion System Industry Trends Table 107. Cardiopulmonary Autotransfusion System Industry Drivers Table 108. Cardiopulmonary Autotransfusion System Industry Restraints Table 109. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiopulmonary Autotransfusion System Product Image Figure 5. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cardiopulmonary Autotransfusion System Market Size (2021-2032) & (US$ Million) Figure 7. Global Cardiopulmonary Autotransfusion System Sales (2021-2032) & (Units) Figure 8. Global Cardiopulmonary Autotransfusion System Average Price (K US$/Unit) & (2021-2032) Figure 9. Unwashed ATS Product Image Figure 10. Washed ATS Product Image Figure 11. Heart Surgery Product Image Figure 12. Great Organ Transplant Surgery Product Image Figure 13. Other Surgery Product Image Figure 14. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Cardiopulmonary Autotransfusion System Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Cardiopulmonary Autotransfusion System Sales by Region in 2025 Figure 20. Global Cardiopulmonary Autotransfusion System Revenue by Region in 2025 Figure 21. North America Cardiopulmonary Autotransfusion System Market Size by Country in 2025 Figure 22. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2032) Figure 23. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021-2032) Figure 24. United States Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Cardiopulmonary Autotransfusion System Market Size by Country in 2025 Figure 28. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2032) Figure 29. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021-2032) Figure 30. Germany Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Country in 2025 Figure 41. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021-2032) Figure 43. China Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Cardiopulmonary Autotransfusion System Market Size by Country in 2025 Figure 52. South America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2032) Figure 53. South America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021-2032) Figure 54. Brazil Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country in 2025 Figure 58. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2021-2032) Figure 60. Egypt Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Cardiopulmonary Autotransfusion System Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021-2032) Figure 66. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021-2032) Figure 67. Global Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Type (2021-2032) Figure 68. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021-2032) Figure 69. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021-2032) Figure 70. Global Cardiopulmonary Autotransfusion System Price (K US$/Unit) by Application (2021-2032) Figure 71. Cardiopulmonary Autotransfusion System Value Chain Figure 72. Cardiopulmonary Autotransfusion System Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Cardiopulmonary Autotransfusion System Industry Opportunities and Challenges

Scope & coverage.

Types
  • Unwashed ATS
  • Washed ATS
Applications
  • Heart Surgery
  • Great Organ Transplant Surgery
  • Other Surgery
Companies covered
  • Haemonetics
  • Medtronic
  • LivaNova
  • Fresenius Kabi
  • Terumo
  • Wandong Health Sources

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cardiopulmonary Autotransfusion System Market Size (2021-2032)
  4. 2.2.2 Global Cardiopulmonary Autotransfusion System Sales (2021-2032)
  5. 2.2.3 Global Cardiopulmonary Autotransfusion System Market Average Price (2021-2032)
  6. 2.3 Cardiopulmonary Autotransfusion System by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Unwashed ATS
  9. 2.3.3 Washed ATS
  10. 2.4 Cardiopulmonary Autotransfusion System by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Heart Surgery
  13. 2.4.3 Great Organ Transplant Surgery
  14. 2.4.4 Other Surgery
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cardiopulmonary Autotransfusion System Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cardiopulmonary Autotransfusion System Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cardiopulmonary Autotransfusion System Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cardiopulmonary Autotransfusion System Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cardiopulmonary Autotransfusion System, Product Type & Application
  8. 3.8 Global Manufacturers of Cardiopulmonary Autotransfusion System, Established Date
  9. 3.9 Global Cardiopulmonary Autotransfusion System Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Haemonetics
  2. 4.1.1 Haemonetics Company Information
  3. 4.1.2 Haemonetics Business Overview
  4. 4.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
  6. 4.1.5 Haemonetics Recent Developments
  7. 4.2 Medtronic
  8. 4.2.1 Medtronic Company Information
  9. 4.2.2 Medtronic Business Overview
  10. 4.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
  12. 4.2.5 Medtronic Recent Developments
  13. 4.3 LivaNova
  14. 4.3.1 LivaNova Company Information
  15. 4.3.2 LivaNova Business Overview
  16. 4.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
  18. 4.3.5 LivaNova Recent Developments
  19. 4.4 Fresenius Kabi
  20. 4.4.1 Fresenius Kabi Company Information
  21. 4.4.2 Fresenius Kabi Business Overview
  22. 4.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
  24. 4.4.5 Fresenius Kabi Recent Developments
  25. 4.5 Terumo
  26. 4.5.1 Terumo Company Information
  27. 4.5.2 Terumo Business Overview
  28. 4.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
  30. 4.5.5 Terumo Recent Developments
  31. 4.6 Wandong Health Sources
  32. 4.6.1 Wandong Health Sources Company Information
  33. 4.6.2 Wandong Health Sources Business Overview
  34. 4.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
  36. 4.6.5 Wandong Health Sources Recent Developments
5 Global Cardiopulmonary Autotransfusion System Market Scenario by Region
  1. 5.1 Global Cardiopulmonary Autotransfusion System Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2021-2032
  3. 5.2.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2021-2026
  4. 5.2.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2027-2032
  5. 5.3 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2021-2032
  6. 5.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2021-2026
  7. 5.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2027-2032
  8. 5.4 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
  9. 5.4.1 North America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
  11. 5.4.3 North America Cardiopulmonary Autotransfusion System Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
  16. 5.5.1 Europe Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
  18. 5.5.3 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
  41. 5.7.1 South America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
  43. 5.7.3 South America Cardiopulmonary Autotransfusion System Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2032)
  2. 6.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2021-2032)
  5. 6.2.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cardiopulmonary Autotransfusion System Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2032)
  2. 7.1.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2021-2032)
  5. 7.2.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cardiopulmonary Autotransfusion System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cardiopulmonary Autotransfusion System Value Chain Analysis
  2. 8.1.1 Cardiopulmonary Autotransfusion System Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cardiopulmonary Autotransfusion System Production Mode & Process
  5. 8.2 Cardiopulmonary Autotransfusion System Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cardiopulmonary Autotransfusion System Distributors
  8. 8.2.3 Cardiopulmonary Autotransfusion System Customers
9 Global Cardiopulmonary Autotransfusion System Analyzing Market Dynamics
  1. 9.1 Cardiopulmonary Autotransfusion System Industry Trends
  2. 9.2 Cardiopulmonary Autotransfusion System Industry Drivers
  3. 9.3 Cardiopulmonary Autotransfusion System Industry Opportunities and Challenges
  4. 9.4 Cardiopulmonary Autotransfusion System Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst